A painless electronic palpation device takes on the clinical breast exam
NCT ID NCT04761055
First seen Jul 30, 2026 · Last updated Jul 31, 2026 · Updated 1 time
Summary
This study compares a handheld device called iBreastExam to the standard clinical breast exam for detecting breast lumps. The iBreastExam uses pressure sensors to create a color map of the breast, highlighting areas that may need further imaging. Researchers will enroll about 300 women undergoing routine mammography to see if the device matches the accuracy of a nurse's manual exam.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- iBreastExam device
- What this could lead to
- If the iBreastExam proves as accurate as a manual exam, it could offer a quick, painless, and standardized way to screen for breast abnormalities.
- What could go wrong
- The device may not detect all abnormalities or may flag false positives, leading to unnecessary imaging. This is an early comparison study, not a proof of improved outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST SCREENING are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
MSK at Ralph Lauren (All Protocol Activities)
New York, New York, 10035, United States
-
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, New York, 10065, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.